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Abstract We have cyclized the polypeptide backbone of L-
lactamase with a short peptide loop as a novel method for protein
stabilization, using intein-mediated protein ligation. Successful
cyclization was proven by mass spectrometry and subsequent re-
linearization by proteolytic cleavage, as well as by resistance
against carboxypeptidase. Under the conditions of the experi-
ment, no disulfide bond is present. The circular form of L-
lactamase was found to be significantly more stable against
irreversible aggregation upon heating than the linear form. The
circular form could be purified from the linear one either by this
heat treatment or by a his-tag which became exopeptidase-
resistant by cyclization. The increased stability of the circular
form is probably due to the decreased conformational entropy in
the unfolded state and in the intermediate states. While the
introduction of additional disulfide bonds for protein stabilization
follows the same rationale, the cyclization strategy may disturb
the structure less and thus constitute a general method for
stabilizing those proteins with N- and C-termini in close
proximity.
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1. Introduction
The engineering of stable proteins is of great technological
and economic importance, since the limited stability of pro-
teins often severely restricts their medical and industrial ap-
plication. The stepwise improvement by a combination of
rationally designed mutations or evolutionary approaches is,
however, still a major undertaking and challenge for every
individual protein. The engineering of novel disul¢de bonds
has been one of the more frequently used strategies to stabilize
proteins. In natural proteins, disul¢de bonds can make sub-
stantial contributions to the stability [1,2] and part of this
e¡ect is presumed to be due to the decrease of the conforma-
tional entropy in the unfolded state [3]. However, more de-
tailed treatments of enthalpic and entropic contributions point
to a more complicated picture, which is protein dependent
[4,5]. Importantly, because of the short reach and hydropho-
bicity of the disul¢de bond, it often has to be engineered in
the interior of the protein, such that the new disul¢de bond
frequently interferes with the remainder of the structure. De-
spite great successes in several cases, an increase in stability
has not been routinely achieved [6,7]. Furthermore, additional
disul¢de bonds usually complicate the production of the pro-
tein.
An alternative way to reduce the conformational entropy in
the unfolded state is the cyclization of the polypeptide back-
bone. Cyclization of peptides is commonly used to reduce
their conformational £exibility, thereby locking them in an
active conformation (for review, see [8]). It has been shown
that the cyclization of peptides frequently improves their in
vivo stability and biological activity [9]. In contrast to pep-
tides, the cyclization of proteins has not been much explored.
Goldenberg and Creighton produced the ¢rst circular protein
from bovine pancreatic trypsin inhibitor (BPTI), a small pro-
tein of 58 amino acids, by chemical cross-linking of the back-
bone termini with a peptide bond [11]. They have found no
signi¢cant stabilization e¡ects by the backbone cyclization,
however, and the characterization of the physicochemical
properties of other cyclized proteins has been limited [10,12^
14]. The better characterization of cyclic peptides than pro-
teins is also due to the fact that cyclic peptides and proteins
have usually been prepared by well established chemical meth-
ods in vitro, which cannot easily be applied to larger proteins.
A general method to produce a circular form of peptides and
proteins from a bacterial expression system would open new
avenues for the physicochemical characterization of such cir-
cular proteins and their subsequent application in biotechnol-
ogy.
Such a general method of cyclization is provided by the
protein splicing reaction. During the course of these studies,
two other reports using this approach have appeared [13,14].
Protein splicing is a self-catalyzed post-translational modi¢ca-
tion, in which a precursor protein is self-spliced into two
polypeptides by excising the protein splicing domain called
intein, or alternatively protozyme, and joining the £anking
protein sequences (N-extein and C-extein) (Fig. 1c) [15,16].
The key chemical step, catalyzed by the intein, is an acyl
migration, leading to the formation of a thioester from a
peptide bond (Fig. 1e), which can thus be attacked by nucle-
ophiles. A partial reaction of a modi¢ed intein, in which the
active site was mutated from HNC to HAC, is also used for
protein puri¢cation [17], where the N-extein can be cleaved o¡
with nucleophiles such as DTT from the intein, which is im-
mobilized by a fused chitin binding domain (CBD).
Inteins can also catalyze a trans-ligation. Two di¡erent
strategies have been used for this purpose. In one approach,
the intein itself has been split and the two halves of the intein
have been re-assembled in vitro, each fused to a di¡erent
extein [18]. In another approach, an intein domain has been
used, carrying the aforementioned HNC to HAC mutation in
the catalytic site, such that the reaction can be triggered with
a thiolate nucleophile such as DTT and subsequently, an ex-
ternal peptide containing a N-terminal cysteine can be linked
as depicted in Fig. 1a [19]. These reactions are very promising
for segmental-speci¢c isotope labelling, as required in NMR
for solving the structures of larger proteins [20]. This protein
ligation utilizing inteins has been called expressed protein
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ligation (EPL) or intein-mediated protein ligation (IPL)
[21,22].
Both types of ligation approaches can in principle be used
to make circular proteins (Fig. 1b and d). In its simplest
form, only a cysteine residue needs to be introduced at the
N-terminus, which will lead to cyclization, provided that
N- and C-termini can reach each other (Fig. 1b). In the
second approach, a circular protein can in principle be pro-
duced by a circular permutation of the precursor protein
containing an intein domain (Fig. 1d). This approach would
have the advantage that it would require only the formation
of the three-dimensional structure and does not require other
factors such as thiolates, making it in principle possible to
produce circular peptides and proteins totally in vivo. Both
approaches may open a new general strategy to produce
cyclic peptides and proteins from a bacterial expression sys-
tem.
In the present paper, we concentrate on the ¢rst approach
and we report the production of a 30 kDa protein, L-lacta-
mase (BLA), with a circular topology, in which the N- and
C-termini are cross-linked with a normal peptide bond (Fig.
2). The circular protein was made from an Escherichia coli
expression system by making use of the enzymatic activity
of an intein domain. Under the conditions of the experiments,
the disul¢de bond of BLA is not present. We veri¢ed the
circular nature of the product by three independent methods,
puri¢ed the circular form by two di¡erent methods and de-
termined that the circular form of BLA is more stable than
the linear form upon heating, as would be expected from
polymer theory.
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2. Materials and methods
2.1. Expression plasmids of TEM-1 BLA
The gene of TEM-1 BLA was ampli¢ed from the plasmid pGEX-
2TK (Pharmacia) with the following two oligonucleotides: 5P-GG-
ATGCATATGTGTGCTAGCGGTGGTGGTCACCCAGAAACG-
CTGG-3P and 5P-CGAATTCCCCGGGTCCCCAATGCTTAATCA-
G-3P. The PCR product was cloned into the vector pTYB2 (New
England Biolabs) between the NdeI and EcoRI sites, resulting in the
plasmid pT2R31E. The mature TEM-1 BLA so obtained has a N-
terminal linker, CAGGGG, and a C-terminal linker, GPGEFLEPG,
fused to the Sce VMA gene (whose active site Asn was replaced with
Ala and linked to the CBD) [17] (Figs. 1b and 3). Three other plas-
mids were derived from this plasmid by replacing the C-terminal
sequence of BLA between the EcoRI and KpnI sites with synthetic
oligonucleotides, yielding the expression plasmids for BLA-His, BLA-
Trb and BLA-S as shown in Fig. 3. The DNA sequences of all con-
structs were con¢rmed with PCR cycle sequencing.
2.2. Cyclization of BLA
The proteins were typically expressed in 2 l bacterial culture of
E. coli ER2566 (New England Biolabs) [22], grown at 22‡C. The
culture was induced with 0.5 mM isopropyl-thio-galactoside at an
OD600 of 0.7, growth was continued for 6 h and the cells were har-
vested, lysed by sonication and subsequently by a French press. The
cell lysate was cleared by centrifugation at 15 000 rpm with an SS34
rotor and then loaded on a chitin column (15 ml) (New England
Biolabs). After washing with loading bu¡er (50 mM Tris pH 8.0,
0.1 mM EDTA, 0.1% Triton X-100, 500 mM NaCl), the chitin beads
were brie£y washed with the cyclization bu¡er (0.2 M NaCl, 0.2 M
sodium phosphate, pH 5.0) and then stirred in 15 ml cyclization
bu¡er, containing 50 mM 2-mercaptoethanesulfonic acid (MENSA),
overnight at room temperature. The supernatant from the beads was
collected, which contains the circular and linear BLA released from
the fusion protein. As the protein is produced in the cytoplasm and
kept under reducing conditions, the single disul¢de bond of BLA does
not form.
Fig. 1. Schematic representation of (a) the EPL with a modi¢ed intein [21,22]. The active site of the intein is modi¢ed from HNC to HAC so
that the protein splicing activity is abolished, but the C-terminus of the N-extein domain can be cleaved by sulfur nucleophiles and at the same
time converted to a thioester, which allows for the subsequent ligation reaction with an external peptide carrying a N-terminal cysteine. (b) Li-
gation reaction as in scheme (a), except that the nucleophilic N-terminal cysteine is located in the same protein. The ligation reaction results in
a circular peptide backbone. (c) Ligation of two extein domains by protein splicing. This is the natural reaction of intein-mediated protein splic-
ing with the wild-type active site residues HNC. (d) Circular permutation of the precursor protein containing an intein domain with a wild-
type active site as in scheme (c). Protein splicing results in a circular protein, with the original N- and C-termini connected by a peptide bond.
(e) The simpli¢ed mechanism of the cyclization reaction. The precursor protein with a N-terminal cysteine undergoes N-S acyl migration. The
intra-molecular thioester can be attacked by thiolate nucleophiles such as MENSA, resulting in cleavage of the fusion protein, carrying now an-
other C-terminal thioester. The released protein with the thioester can react with a N-terminal cysteine either in an intra-molecular or inter-mo-
lecular reaction.
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2.3. Stability test of circular and linear BLA
The stability against heat precipitation was quantitatively tested as
follows. Two-hundred Wl of a 40 WM protein solution, directly taken
from the ligation reaction in the reaction bu¡er (200 mM NaCl, 200
mM NaPi, 50 mM MENSA, pH 5.0) was incubated at various tem-
peratures (from 40 to 70‡C). The insoluble fraction was removed by
centrifugation at 20 800Ug for 30 min. The protein pellets and the
supernatant, precipitated with 5% TCA, were dissolved with sodium
dodecyl sulfate (SDS) loading bu¡er. Each soluble and insoluble frac-
tion was analyzed with SDS-polyacrylamide gel electrophoresis
(PAGE). After Coomassie brilliant blue staining, the individual bands
were quanti¢ed with a densitometer (Model 300A, Molecular Dynam-
ics).
2.4. Linearization of circular BLA
The supernatant from the cyclization reaction of BLA-Trb, in
which a thrombin-speci¢c cleavage site was introduced (Fig. 3), was
incubated at 46‡C for 1 h in order to selectively precipitate most of
the linear form of BLA-Trb. The insoluble fraction was removed by
centrifugation and the bu¡er was changed to 50 mM Tris, 1 mM
EDTA, pH 7.0, with a Microcon concentrator (Amicon). The circular
protein was incubated for 2 h at room temperature with 0.01 U of
thrombin (Roche Diagnostics).
3. Results
We chose TEM-1 BLA (wild-type 263 amino acids) as a
model protein for cyclization since its activity and three-di-
mensional structure as well as its stability properties have
been well characterized [23^25]. Its N- and C-termini are in
close proximity in the three-dimensional structure (Fig. 2). We
introduced a cysteine residue after the start codon, which
becomes the N-terminal residue, as the starting methionine
is usually removed, if cysteine is the following residue [28].
Five additional amino acids were added behind the N-termi-
nal cysteine in front of the BLA sequence, while nine residues
were fused to its C-terminal end, followed by the modi¢ed Sce
VMA gene, itself fused to a CBD [17] (Figs. 1e and 3). After
cyclization, the original N- and C-termini of BLA would then
be connected by a loop of an additional 15 amino acids (Figs.
2 and 3). Three other variants were constructed, in which the
sequence of the C-terminal linker of BLA was modi¢ed for
alternative puri¢cation and analytical procedures (Fig. 3, see
Section 2). The proteins were expressed in E. coli and the
cyclization reaction was performed in vitro, after the protein
was bound to the chitin column and the column was washed.
The chitin beads were incubated with 50 mM MENSA over-
night at room temperature in order to cleave the fusion pro-
tein and simultaneously to obtain a thioester at the C-termi-
nus, followed by the cyclization reaction as depicted in Fig.
1e. SDS-PAGE analysis of the reaction mixture indicated two
major closely spaced bands with an apparent molecular
weight of about 30 kDa. We now provide evidence that the
more slowly migrating one is the linear form of BLA, while
the faster migrating one is the circular form.
The successful cyclization of the protein was con¢rmed by
several independent methods. First, both bands in SDS-
PAGE were analyzed by N-terminal Edman degradation
Fig. 2. Models of the three-dimensional structure of circular and linear BLA (BLA-S). The models were created based on the coordinates of
the PDB entry 1AXB with MOLMOL [31,32]. NH2 and COOH denote N- and C-termini, respectively, in the linear form. The introduced
N-terminal linker is colored black and the C-terminal linker is colored dark gray.
Fig. 3. Amino acid sequences of the linkers at the N- and C-termini
of TEM-1 BLA. The linker sequences are underlined. The methio-
nine start codon, which gets cleaved during biosynthesis, and part
of the sequence from Sce VMA are also shown. The his-tag and the
thrombin site are indicated in bold (see text).
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and amino acid analysis after blotting the gel to a PVDF
membrane. The amino acid sequence ASGGG was observed
by N-terminal Edman degradation from the band with a slow-
er mobility, indicating that the N-terminal Met and Cys have
been lost (labelled lin in Fig. 4a). On the other hand, the
sequence of the N-terminus of the faster migrating band could
not be determined, indicating that the N-terminus of this pro-
tein is protected (indicated by circ in Fig. 4a). This is also
consistent with the fact that the cyclization can be prevented
by eluting the protein into denaturants or by elution with
nitrogen nucleophiles such as NH2OH, both exclusively re-
sulting in the upper band in SDS-PAGE (data not shown).
Second, after removing the linear form by heat incubation (see
below), the molecular mass of the presumed circular form of
BLA was measured by ESI-mass spectroscopy, resulting in a
mass about 16 þ 2 Da smaller than the expected molecular
mass of the linear form (Fig. 5). Third, the re-linearization
of the circular protein by limited proteolysis was tested. For
this purpose, a variant of BLA, BLA-Trb, was constructed
with the sequence LVPRG introduced at the end of BLA,
such that the successful cyclization would yield the sequence
LVPRGC, which is similar to that of the thrombin-speci¢c
recognition sequence LVPRGS [29] (Fig. 3). Indeed, the di-
gestion of cyclic BLA-Trb by thrombin resulted in a linear
form of BLA-Trb, which migrates more slowly than the cir-
cular form and co-migrates exactly with the linear form (Fig.
6). The disappearance of the lower band (circular form) and
the re-appearance of the upper band (linear form) after
thrombin digestion thus indicates that circular BLA-Trb could
be re-linearized into the linear form by limited proteolysis. A
minor form of about 60 kDa was also seen, which was di-
gested by thrombin. This form is most likely derived from an
inter-molecular ligation reaction (see below).
3.1. Stability against exoproteolytic digestion
Since circular proteins lack both N- and C-termini, they
should be insensitive to the proteolysis catalyzed by exopepti-
dases. Hence, we tested the sensitivity against carboxypepti-
dase Y. At the C-terminus, a very short tag of three histidine
residues was introduced (Fig. 3). Both the cyclized and the
linear BLA, carrying this his-tag, can bind to an immobilized
metal ion a⁄nity chromatography (IMAC) column. The mix-
Fig. 4. (a) SDS-PAGE analysis of the soluble and insoluble fraction after 1 h of incubation at di¡erent temperatures. s and p denote soluble
fraction and insoluble fraction, respectively. lin and circ indicate the linear form and the circular form, respectively. For bands a and b, see
text. (b) Plot of the soluble fraction of monomeric BLA-S after 1 h incubation at di¡erent temperatures. Filled circles and open rectangles indi-
cate the circular and the linear form of BLA-S, respectively. A midpoint of the transition of 45‡C was obtained for the linear form and 50‡C
for the circular form.
Fig. 5. Mass spectra of BLA. The molecular mass of the circular
form of BLA is expected to be 30 205.4 Da. The peak at 30 121 Da
corresponds to the linear form which has lost the N-terminal Cys.
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ture of both forms obtained from the cyclization reaction was
then treated with carboxypeptidase Y and passed through the
IMAC column. In the presence of 10 mM imidazole, to sup-
press any non-speci¢c binding, the linear form passed right
through the column without binding, as the his-tag had been
quantitatively removed by the exopeptidase (Fig. 7b, lane 2
and 3). The elution fraction from the IMAC column only
contained the lower band, which is the circular form retaining
the his-tag (Fig. 7b, lane 4). This experiment clearly demon-
strates the resistance of the circular form to proteolysis by
carboxypeptidase as well as constituting an e⁄cient method
to purify the circular protein from the linear form.
3.2. Stability enhancement by backbone cyclization
The cross-linking of polymer chains will reduce the confor-
mational entropy of their unfolded state, resulting in stabili-
zation of the native state [3]. A N- to C-terminal cyclization of
a protein should therefore have the maximal e¡ect on the
conformational entropy. Here, we have successfully produced
a circular protein of 278 amino acids from a bacterial expres-
sion system and could thus test the hypothesis of stabilization
by cyclization of a protein. As a ¢rst example, we monitored
the irreversible aggregation upon heating, because the free
energies of related proteins are often well correlated with
the temperature at which aggregation initiates, even though
there are exceptions [26,27]. Thus, the mixture of linear and
circular forms from the reaction mixture was incubated at
various temperatures for 1 h. Then, the precipitate and the
soluble fraction were quanti¢ed by SDS-PAGE as shown in
Fig. 4a. The protein bands were analyzed densitometrically
and this is plotted in Fig. 4b. At 50‡C, nearly 100% of the
linear form (indicated as lin in Fig. 4a) precipitates, but 50%
of the circular form (indicated by circ in Fig. 4a) stays in the
soluble fraction. As the midpoint of the transition (Tm), we
obtained 45‡C for the linear form of BLA-S and 50‡C for the
circular form of BLA-S under these conditions, indicating a
stability enhancement of 5‡C by cyclization. This increased
heat stability of the circular form can also be used for the
separation of the circular form from the linear one. This pu-
ri¢cation method was applied in the re-linearization experi-
ment of circular BLA-Trb in Fig. 6.
We observed not only two major bands but also additional
weaker bands with larger molecular weights (Figs. 6 and 4a).
This can be interpreted by the fact that not only cyclization
but also dimerization and polymerization of the protein can
take place by an inter-molecular reaction with the activated
C-terminal thioester, depending on the protein concentration
[13] (Fig. 1a,e). In Fig. 4, there are four predominant bands in
the reaction mixture (indicated by circ, lin, a and b). We have
identi¢ed the lower two bands (circ and lin in Fig. 4) of about
30 kDa as the circular and linear monomeric forms. One of
the additional bands of about 60 kDa, most likely the upper
one, is expected to be the linear dimer (labelled a in Fig. 4).
Such a polymerization of proteins has been observed in other
proteins [13]. The nature of the lower other band of about 60
kDa (labelled b in Fig. 4), which is more stable against heat
precipitation, is not clear and the N-terminus of that protein
was not accessible by N-terminal Edman degradation. Further
work is required to delineate the topology of these dimeric
species.
4. Discussion
The utility of backbone cyclization has been well appreci-
ated in peptides and it has been demonstrated for a large
number of peptidic systems that their biological activity and
in vivo stability can be improved by cyclization. Therefore,
cyclization of small peptides has often been used for restrict-
ing their conformation to the active form for pharmaceutical
applications (see [8] for a review). The only circular protein,
Fig. 7. (a) Schematic drawing of the separation of the circular form
from the linear form with a C-terminal his-tag and carboxypepti-
dase. (b) SDS-PAGE analysis of the puri¢cation of the circular
form of BLA-His. M: Marker. 1: Before loading on the IMAC col-
umn. 2: Flow through from the IMAC column. 3: Wash from the
IMAC column. 4: Elution of the IMAC column with 200 mM imi-
dazole.
Fig. 6. Time course of the digestion of the circular form of BLA-
Trb. 0 min: before addition of thrombin. 5 min, 30 min: time after
addition of thrombin. The positions of the circular and linear form
of BLA-Trb are indicated by lines. For bands a and b, see text.
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where the e¡ect on stabilization has been studied, is BPTI
[11,10]. However, it contains three disul¢de bonds in 58 amino
acids and does not fold in the reduced state. Therefore, the
comparison had to be made indirectly by investigating the
redox reaction of each disul¢de bond, making it more di⁄cult
to treat the e¡ect of the backbone cyclization quantitatively.
No signi¢cant stabilization e¡ect by the cyclization of BPTI
was observed, possibly because the direct cross-linking of the
original N- and C-termini with a peptide bond is structurally
not ideal, as it may introduce an unfavorable strain in the
native structure [10^12]. Thus, these pioneering experiments
may not allow for a general conclusion about the e¡ect of
cyclization on stability.
In the present article, we have applied IPL to produce a
circular backbone of BLA of 30 kDa. We could indeed dem-
onstrate that the circular form was more stable than the linear
form against irreversible aggregation upon heating. Under the
conditions of our experiment, no disul¢de bond is formed, as
the protein was produced in the cytoplasm and kept under
reducing conditions. The stabilizing e¡ect of the polypeptide
backbone cyclization is consistent with an e¡ect on the con-
formational entropy of the unfolded state, as predicted by the
polymer theory. It also suggests, however, that the aggrega-
tion-prone partially unfolded state of the protein, induced by
heat incubation, can also be depopulated by cyclization. In
contrast to engineering new disul¢de bonds, the N- and C-
termini, when connected by a ‘loose-¢tting’ loop, will cause
essentially no strain on the rest of the structure and this e¡ect
should be largely entropic. This is not the case for engineered
disul¢de bonds [5].
Interestingly, a surprisingly high fraction of proteins ap-
pears to have N- and C-termini close to each other [30]. N-
or C-termini of proteins are often found to be £exible, as
evidenced by NMR or the higher B-factors in X-ray crystal-
lography, where they may even be completely invisible. In
these cases, therefore, the cross-linking of the protein termini
in close proximity would not be expected to cause any unfav-
orable constraints on the folded structures. Based on our ob-
servation of the stabilizing e¡ect by cyclization, we propose
the cross-linking of C- and N-termini in close proximity with
a peptide loop as an alternative strategy for protein stabiliza-
tion and we suggest that this approach might be of rather
general utility. The further biophysical characterization of
the thermodynamic parameters, as well as the folding and
unfolding pathways of both circular and linear forms, will
provide more detailed insights into the mechanism of the
stability enhancement by the cyclization and the importance
of termini in protein folding.
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